Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis

The establishment of a new Category I CPT code for OGM implies that it has met the standards of acceptance by the medical community, in contrast to a Category III code, which is generally applied to emerging technologies. As part of the application review process, the panel collects input from stakeholders across the health care community to ensure CPT content reflects the coding and data-driven demands of modern health care. About Bionano Laboratories: About Bionano For more information, visit www.bionano. ...